Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Safety First: Considerations When Formulating High Potency Compounds
Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
Insights Into Evionnaz's new R&D Center
Pharmaceutical innovation depends on speed and smarter decisions. Discover how advanced R&D technologies and real-time insights are helping accelerate development.
-
Three Success Factors To Accelerate Your Program To Clinical Trial
Accelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.
-
The Delicate Dance: When Phase-Appropriate Decisions Carry More Risk
Early drug development demands speed, but some decisions carry long-term consequences. Learn which process and analytical choices require teams to look beyond the next milestone.
-
Can Targeted LNP Delivery Take In-Vivo CAR-T Therapy Beyond The Liver?
Achieving successful extrahepatic CAR T delivery with LNPs requires addressing the unique biological and technological barriers and designing targeting approaches that leverage innovative LNP design.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Streamline Antibody Analysis For Faster Protein Characterization
Strengthen your antibody characterization. Explore approaches for improving sizing accuracy, resolving heterogeneity, and generating reproducible data across demanding biopharmaceutical workflows.
-
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins
Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
-
Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity
Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.
-
Differentiate Challenging Site-Specific Isomeric Amino Acids
Learn how high-resolution ion mobility, pre-IMS fragmentation, and product ion analysis can resolve difficult peptide isomers and localize structural differences, supporting confident characterization.
-
Increase Throughput For Intact Mass Confirmation And Impurity Screening
Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.
FORMULATION DEVELOPMENT SOLUTIONS
- Waters Liquid Chromatography And LC-MS Solutions
- Picoliter Dispensing Redefined, Now For Single Cells Too
- HPLC Made For Tomorrow
- A Streamlined Approach For The APC Labeling/Conjugation Of Antibodies
- Human Proximal Tubule Kidney Bio-Kit
- OSD Capabilities Overview
- Empowering Biologics Development With HRMS Services
- Adare Pharma Solutions (APS) Orbis Overview
- Neotame And Sucralose: Two Ways To Ace The Taste Test
- Molecule To Cure. Fast.
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Germfree Announces New Chief Financial Officer And Chief Commercial Officer
- Siegfried Delivers Profitable Growth And Confirms Outlook
- Siegfried Strengthens Manufacturing Network With New Large-Scale Drug Substance Facility In Minden
- Siegfried Successfully Places Senior Bonds Of CHF 200 Million
- Siegfried Included In Dow Jones Best-In-Class Europe Index
- Siegfried DINAMIQS Receives Swissmedic License For Viral Vector Manufacturing
- Siegfried Obtains Antitrust Clearance For Acquisition Of Three Drug Substances Sites In The US And Australia
- Siegfried Shareholders Approve All Proposals At Annual General Meeting 2026
- Siegfried Delivers Strong Profitability And Continued Growth
- METTLER TOLEDO Showcases New Product Inspection Technologies At Pack Expo